Pharma Focus Asia
KP - Choose our fully recyclable blister films

First-of-its-kind Doptelet will soon be Available to Control Life-threatening Bleeding

Dova Pharmaceuticals announced that US Food and Drug Administration (FDA) has given green signal to Doptelet (avatrombopag) prescriptive medicine for the treatment of thrombocytopenia in adult patients affecting with a chronic liver disease.

Doptelet is used to treat low platelet counts in adults affecting with severe liver disease and who are scheduled to undergo a treatment.

With the help of Doptelet, the CLD patients can minimise platelet transfusion prior to a procedure by increasing platelet counts to the target level of greater or equal to 50,000 per microliter and reduce the risk of bleeding.

A through trials of testing and reviewing was conducted by FDA in adults suffering with thrombocytopenia included Two global Phase 3, double-blind, placebo-controlled trials (ADAPT-1 [N=231] and ADAPT-2 [N=204]).

On a daily basis for 5 days the patients were allotted to consume 40 mg/60 mg of avatrombopag depending on their Baseline platelet counts (40 to <50>

Thrombocytopenia is a depletion of platelets in the blood of patients suffering from CLD.

Nearly 70,000 patients with CLD have a platelet count of less than 50,000/µL. Every year these patients require multiple invasive diagnostic and therapeutic procedures that lead to a high risk of bleeding.

Besides, Dova is also working on the evaluation of DOPTELET in the treatment of chemotherapy-induced thrombocytopenia (CIT).

The breakthrough medicine is scheduled to launch in the market in the month of June 2018.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoBora Pharmaceuticals - Free WhitepaperThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 2023Reuters Events - Pharma Customer Engagement USA 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023
MasterControl - 6 Essential Features in an eQMS